Prosensa to Participate at Upcoming Investor Conferences

By GlobeNewswire,  January 31, 2014, 09:16:00 AM EDT


Leiden, The Netherlands, Jan. 31, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ:RNA) announced today that it is schedule to participate at the following investor conferences in  February.

  • 16th Annual BIO CEO & Investor Conference, Monday, February 10, 2014
  • Corporate Presentation: 9:30 a.m. Eastern Time (webcast available)
  • Panel Participation: 2:00 p.m. Eastern Time (no webcast available)
  • Leerink Partners Global Healthcare Conference 2014,Thursday, February 13, 2014
  • Fireside Chat: 11:35 a.m. Eastern Time (webcast available)
  • Canaccord Genuity Orphan Drug One-on-One Day, Monday, February 24, 2014   
  • 2014 Citi Healthcare Conference, Tuesday, February 25, 2014
  • Panel Participation, 9:40 a.m. Eastern Time (no webcast available)

Live webcasts where available can be accessed through the Investors & Media section of the Prosensa corporate website at http://ir.prosensa.eu/events.cfm and will be archived for 90 days.

About Prosensa Holding N.V.

Prosensa (NASDAQ:RNA) is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. www.prosensa.com

CONTACT: Prosensa Holding N.V.Celia Economides, Senior Director IR & Corporate Communications
         Phone: +1 917 941 9059
         Email: c.economides@prosensa.nl

Source: Prosensa Holding N.V.

This article appears in: News Headlines

Referenced Stocks: RNA


Latest News Video





Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.15 0.02 ▲ 0.12%
FB $ 58.94 0.78 ▼ 1.31%
GE $ 26.56 0.44 ▲ 1.68%
QQQ $ 86.20 0.02 ▲ 0.02%
CSCO $ 23.21 0.18 ▲ 0.78%
MU $ 23.91 1.43 ▲ 6.36%
ZNGA $ 4.289 0.18 ▲ 4.36%
MSFT $ 40.01 0.39 ▼ 0.97%

As of 4/17/2014, 04:07 PM